TP53 and colorectal cancer: Oral administration of quercetin reduced tumor volume and activated AMPK in HT-29 tumor xenograft mice [26], and berberine activated AMPK, decreased mTOR (a downstream target of AMPK) levels, and phosphorylated p53 in colorectal cancer cells [27].